Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Journal of the National Cancer Institute|December 17, 2011
Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cellsRyuichi Kanai, Samuel D Rabkin, Stephen Yip, et al.
Journal of Virology|May 26, 2018
Restriction of Replication of Oncolytic Herpes Simplex Virus with a Deletion of γ34.5 in Glioblastoma Stem-Like CellsCole Peters, Max Paget, Kizito-Tshitoko Tshilenge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumorsTa-Chiang Liu, Tingguo Zhang, Hiroshi Fukuhara, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 22, 2022
Histone deacetylase inhibitors enhance oncolytic herpes simplex virus therapy for malignant meningiomaYoichiro Kawamura, Lingyang Hua, Alessandra Gurtner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 15, 2011
Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 gliomaWei Zhang, Giulia Fulci, Jason S Buhrman, et al.
Neoplasia (New York, N.Y.)|June 5, 2013
Combination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma modelsWei Zhang, Giulia Fulci, Hiroaki Wakimoto, et al.
Nature Communications|July 4, 2019
Myc targeted CDK18 promotes ATR and homologous recombination to mediate PARP inhibitor resistance in glioblastomaJian-Fang Ning, Monica Stanciu, Melissa R Humphrey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2020
Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in GlioblastomaJuri Kiyokawa, Yoichiro Kawamura, Shanawaz M Ghouse, et al.
Acta Neuropathologica Communications|December 14, 2020
Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastomaMing Li, Guoping Li, Juri Kiyokawa, et al.
International Journal of Cancer|August 13, 2017
Blockade of transforming growth factor-β signaling enhances oncolytic herpes simplex virus efficacy in patient-derived recurrent glioblastoma modelsShinichi Esaki, Fares Nigim, Esther Moon, et al.
Pageof 9